AtRial fibrillation ablation to prevent disease progression of AF-induced atrial Cardiomyopathy in womEn and me
Phase 3
- Conditions
- Atrial fibrillation10007521
- Registration Number
- NL-OMON56762
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 604
Inclusion Criteria
- confirmed atrial cardiomyopathy (LAVI >34 ml/m2)
- ECG-confirmed atrial fibrillation
- age: 65-80 years old
Exclusion Criteria
- permanent AF
- previous AF ablation
- heart failure NYHA III/IV
- severe aortic or mitral valve disease
- life expectancy < 1 year
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method